Skip to Content

Diphtheria, Tetanus, Pertussis (Acellular, Component), Hepatitis B (rDNA), Poliomyelitis (Inactivated) And Haemophilus Type b Conjugate Vaccine (Adsorbed)


Ph. Eur.

ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Vaccine: Combination of bacterial vaccine (toxoids) and inactivated virus

Active immunisation against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and haemophilus influenzae B

Chemical Name

Combined vaccine composed of: diphtheria formol toxoid; tetanus formol toxoid; antigenic components of Bordatella pertussis; hepatitis B surface antigen (HBsAg); human poliovirus types 1, 2 and 3 and polyribosyliribitol phosphate (PRP) (Ph. Eur.)

Foreign Names

  • Vaccinum diphtheriae, tetani, pertussis sine cellulis ex ele (Latin)
  • Diphtherie-Tetanus-Pertussis(azellulär, aus Komponenten)-Hep (German)
  • Vaccin diphthérique, tétanique, coquelucheux (acellulaire, m (French)
  • Vacuna antidiftérica, antitetánica, antipertussis (component (Spanish)

Generic Names

  • DTaP/HepB/IPV/Hib (IS)
  • DTPa-HBV-IPV/Hib vaccine (IS)
  • Diphtheria, Tetanus, Pertussis (Acellular, Component), Hepatitis B (r (PH: BP 2016, Ph. Eur. 8)
  • Diphtherie-Tetanus-Pertussis(azellulär, aus Komponenten)-Hepatitis-B(r (PH: Ph. Eur. 8)
  • Vaccin diphthérique, tétanique, coquelucheux (acellulaire, multicompos (PH: Ph. Eur. 8)
  • Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis pra (PH: Ph. Eur. 8)

Brand Names

  • Hexacima
    Sanofi Pasteur, Poland
  • Hexaxim
    Sanofi Pasteur, Bosnia & Herzegowina; Sanofi Pasteur, Malaysia; Sanofi Pasteur, Thailand
    Sanofi Pasteur Sa, Myanmar
  • Hexyon
    Sanofi Pasteur, France; Sanofi Pasteur MSD, Germany; Sanofi Pasteur MSD, Spain; Sanofi Pasteur MSD, Poland
  • Infanrix
    GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Mexico
  • Infanrix Hexa
    GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Poland
  • Infanrix hexa (DTPa-HepB-IPV+Hib) (pediatric)
    GlaxoSmithKline, Switzerland
  • Infanrix Hexa (pediatric)
    GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline Pharma, Austria; GSK, Belgium; Wellcome Limited, Bosnia & Herzegowina
  • Infanrix hexa (pediatric)
    GlaxoSmithKline, Canada; GlaxoSmithKline, Germany; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden
  • Infanrix tetra (pediatric)
    GlaxoSmithKline Laboratoire Pharmaceutique, France
  • Infanrix-IPV+Hib (pediatric)
    GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia
  • Infanrixquinta (pediatric)
    GlaxoSmithKline Laboratoire Pharmaceutique, France
  • Pediacel
    Sanofi Pasteur, Croatia (Hrvatska); Sanofi-aventis, Czech Republic
  • Quinvaxem (pediatric)
    Novartis Vaccines, Thailand
  • Tritanrix HB+Hiberix
    GlaxoSmithKline, Chile


ISInofficial Synonym
PHPharmacopoeia Name
Ph. Eur.European Pharmacopoeia

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.